Medical Innovation Acceleration Act of 2025

House Bill

H.R. 88

119th Congress

Medical Innovation Acceleration Act of 2025

In Committee

Introduced:Jan 3, 2025

Primary Sponsor

Andy Biggs

R - AZ

Cosponsors

0

Quick Stats

Summary

This bill exempts noninvasive diagnostic devices from FDA regulation. It applies to devices that do not penetrate skin, are not inserted into the body, cause only temporary tissue effects, and do not use ionizing radiation.

Latest Action

Referred to the House Committee on Energy and Commerce.

Introduced1/3/2025

StatusReferred to the House Committee on Energy and Commerce.

ChamberHouse

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Medical Innovation Acceleration Act of 2025

This bill exempts noninvasive diagnostic devices from FDA regulation. It applies to devices that do not penetrate skin, are not inserted into the body, cause only temporary tissue effects, and do not use ionizing radiation.

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill exempts noninvasive diagnostic devices from FDA regulation. It applies to devices that do not penetrate skin, are not inserted into the body, cause only temporary tissue effects, and do not use ionizing radiation.

Bill Number: 88
Introduced: 1/3/2025
Status: Referred to the House Committee on Energy and Commerce.

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: Medical Innovation Acceleration Act of 2025
Bill Number: 88
Sponsor: No sponsor
Status: Referred to the House Committee on Energy and Commerce.
Introduced: 1/3/2025
Summary: This bill exempts noninvasive diagnostic devices from FDA regulation. It applies to devices that do not penetrate skin, are not inserted into the body, cause only temporary tissue effects, and do not use ionizing radiation.

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill exempts noninvasive diagnostic devices from FDA regulation. It applies to devices that do not penetrate skin, are not inserted into the body, cause only temporary tissue effects, and do not use ionizing radiation.

Last updated: 1/5/2026

Official Summary

Congressional Research Service summary

Medical Innovation Acceleration Act of 2025This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration.The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.

Key Points

Main provisions of the bill

Exempts noninvasive diagnostics from FDA
Covers non-penetrating devices
Excludes ionizing radiation devices
Accelerates medical innovation
Reduces regulatory burden on diagnostics

How This Impacts Americans

Potential effects on citizens and communities

Medical device companies could bring noninvasive diagnostics to market faster. Patients could have earlier access to diagnostic technologies. Critics worry about reduced safety oversight for these devices.

Policy Areas

No policy areas assigned yet.

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

88, 119th Congress (2025). "Medical Innovation Acceleration Act of 2025". Source: Voter's Right Platform. https://votersright.org/bills/118-hr-88

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.